Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). - Derman BA; Major A; Cooperrider J; Jiang K; Ramsland A; Karrison T; Kubicki T; Jakubowiak AJ (Blood cancer journal, 2024)